Leo O'Connor

Policy and Regulation
President Biden launches $50M initiative to improve cancer outcomes in low-income areas
The award creates five Centers for Cancer Control Research in Persistent Poverty Areas to advance key priorities of the Administration’s Cancer Moonshot.
June 26, 2023
Business Hands Cooperation Social
Payor Coverage
Report shows Medicare risked up to $888M in improper payments for molecular pathology test
The HHS Office of Inspector General analyzed Medicare Part B claims associated with payments for more than 450,000 genetic tests billed under Current Procedural Terminology (CPT) code 81408.
June 23, 2023
Money Bag Grant Award Social
Business Insights
Week in Review: Quest to offer ctDNA MRD testing | Exact Sciences develops next-gen Cologuard | Detecting Candida auris
Quest Diagnostics completed its previously announced acquisition of Haystack Oncology, a developer of minimal-residual disease (MRD) testing technology.
June 22, 2023
Leo Photo June 8
Colorectal Cancer
Next-gen Cologuard demonstrates 94% sensitivity, 91% specificity for colorectal cancer detection
The firm also entered collaborations related to next-generation technology for ultra-sensitive detection of molecular residual disease (MRD) and ongoing research, as well as for the development of its multicancer early detection (MCED) approach.
June 21, 2023
Exact Sciences Corporation Social
Tuberculosis
Qiagen describes systematic review for IGRA TB test, blood collection tubes
The study including 4,050 subjects highlights the value of the TB2 tube and the detection of CD8 T-cell responses for immunocompromised patients, a key risk group for tuberculosis disease, the firm said.
June 15, 2023
Bacteria Mycobacterium Tuberculosis Social
Business Insights
Week in Review: Biocartis layoffs | Predicting preeclampsia outcomes | Cystic fibrosis screening
Roche announced that its Cobas HPV test has been awarded WHO prequalification, expanding the cervical cancer screening tool's availability in countries that rely on the global organization’s list of prequalified suppliers to purchase tests.
June 15, 2023
Leo Photo June 8
Financial Results
Biocartis to lay off 140 people in company reorganization
The Mechelen, Belgium-based supplier of instruments and tests said the plan would reduce operating expenses by about 18 million euros annually.
June 15, 2023
Genetics Dna Money Social
Business Insights
Week in Review: Molecular testing at home | C. auris detection from blood | ASCO presentations
At-home testing got a boost this week when the FDA granted marketing authorization for the Cue Health COVID-19 Molecular Test.
June 8, 2023
Leo Photo June 8
Sepsis
Prenosis nabs $749K federal contract to study clinical utility of AI-based diagnostic tool for sepsis
The firm’s Sepsis ImmunoScore is a pathogen-agnostic, host-based digital diagnostic tool that uses artificial intelligence/machine learning to predict sepsis using clinical parameters and protein biomarkers.
June 7, 2023
Artificial Intelligence Ai Social
Regulatory Approval
Cue Health granted first traditional FDA authorization for at-home test to detect respiratory illness
The Cue COVID-19 Molecular Test detects genetic material from SARS-CoV-2 virus in nasal swabs from adults with signs and symptoms of upper respiratory infection.
June 6, 2023
Fda Button Social
Page 1 of 17
Next Page
Top Stories
Kidney Social
Artificial Intelligence
AI model reveals kidney tumor features, potential for treatment response prediction
Researchers at the Dana-Farber Cancer Institute have trained artificial intelligence (AI) models to assess the clinical features of kidney cancer tumor samples to predict how tumors may respond to immune therapy.
Breast Cancer3 Social
Breast Cancer
Consumer genetic testing may misrepresent breast cancer risk: Study
Dna Genome Gene Targeted Social
Financing
Rome Therapeutics raises $72M in series B financing
Lab Scientists Social
Regulatory Guidance
NIH to require international collaborators to share all data
At-home or Lab-based STI testing/collection
Sponsor Content
At-home or Lab-based STI testing/collection
More in Home
AI model reveals kidney tumor features, potential for treatment response prediction
Researchers at the Dana-Farber Cancer Institute have trained artificial intelligence (AI) models to assess the clinical features of kidney cancer tumor samples to predict how tumors may respond to immune therapy.
September 22, 2023
Kidney Social
Consumer genetic testing may misrepresent breast cancer risk: Study
Women are being told they are at high risk of breast cancer from consumer genetic test results which do not take family history into account, say researchers.
September 21, 2023
Breast Cancer3 Social
Rome Therapeutics raises $72M in series B financing
Biotech company Rome Therapeutics has raised a further $72 million in financing to develop medicines for autoimmune diseases and continue its exploration of the “dark genome.”
September 20, 2023
Dna Genome Gene Targeted Social
NIH to require international collaborators to share all data
Despite concerns from researchers and organizations, the U.S. National Institutes of Health (NIH) will implement its new mandate requiring foreign partners to share raw data and notebooks at regular set intervals with their primary U.S. grant recipients.
September 22, 2023
Lab Scientists Social
Many British health trusts slow to adopt electronic records systems, shows BMJ survey
Many health organizations in England are still reliant on paper patient notes and drug charts, despite progress toward electronic records and prescribing, The BMJ has found.
September 22, 2023
Doctor Fills Patient Medical Record Social
Danaher cuts cost of rapid TB test after years of pressure from activists
Danaher has cut the cost of one of its tuberculosis (TB) tests in less developed countries after years of public pressure to lower the price.
September 21, 2023
Bacteria Mycobacterium Tuberculosis Social
Protein biomarker may aid in early Parkinsonian disorders detection
A protein biomarker present in cerebrospinal fluid and blood plasma may be useful for the early diagnosis of Parkinsonian disorders.
September 21, 2023
Parkinsons Lewy Bodies Social
Day Zero Diagnostics completes $16M financing round
Day Zero Diagnostics has completed a $16 million financing round, executed as a convertible note.
September 20, 2023
Research Money Social
Polygenic risk scores from multi-ancestry GWASs more accurate in diverse groups: Study
Polygenic risk scores (PRS) derived from multi-ancestry genome-wide association studies (GWASs) outperform PRSs based on single-ancestry GWASs in underrepresented populations, new research shows.
September 21, 2023
Genome Sequence Barcode Social
Researchers develop signature for scoring thyroid cancers
A team led by researchers at Vanderbilt University Medical Center has developed a signature for thyroid cancer aggressiveness that incorporates immune and other microenvironment features through multiomic analyses.
September 20, 2023
Thyroid Social
NIH starts early-phase trial of second-generation universal flu vaccine candidate
The U.S. National Institutes of Health (NIH) has begun an early-phase clinical trial of its second-generation universal flu vaccine candidate.
September 20, 2023
Needle Shot Vaccine Teenager Social
Broken String Biosciences raises $15M in series A financing round
Broken String Biosciences has closed a $15 million series A financing round.
September 19, 2023
Dna Sequence Shadow Social
Page 1 of 91
Next Page